60 Degrees Pharmaceuticals, Inc. (SXTP)
1.08
-0.05
(-4.42%)
USD |
NASDAQ |
Aug 24, 16:00
1.09
+0.01
(+0.93%)
After-Hours: 20:00
60 Degrees Pharmaceuticals Enterprise Value : 11.48M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 11.48M |
| August 21, 2026 | 11.62M |
| August 20, 2026 | 11.62M |
| August 19, 2026 | 11.62M |
| August 18, 2026 | 11.59M |
| August 17, 2026 | 11.48M |
| August 14, 2026 | 11.79M |
| August 13, 2026 | 11.75M |
| August 12, 2026 | 11.62M |
| August 11, 2026 | 11.62M |
| August 10, 2026 | 11.62M |
| August 07, 2026 | 11.59M |
| August 06, 2026 | 11.67M |
| August 05, 2026 | 11.85M |
| August 04, 2026 | 11.88M |
| August 03, 2026 | 11.70M |
| July 31, 2026 | 11.72M |
| July 30, 2026 | 11.93M |
| July 29, 2026 | 12.57M |
| July 28, 2026 | 12.60M |
| July 27, 2026 | 12.79M |
| July 24, 2026 | 12.55M |
| July 23, 2026 | 12.57M |
| July 22, 2026 | 12.73M |
| July 21, 2026 | 12.79M |
| Date | Value |
|---|---|
| July 20, 2026 | 12.63M |
| July 17, 2026 | 12.63M |
| July 16, 2026 | 12.65M |
| July 15, 2026 | 12.73M |
| July 14, 2026 | 12.49M |
| July 13, 2026 | 12.47M |
| July 10, 2026 | 12.76M |
| July 09, 2026 | 12.76M |
| July 08, 2026 | 12.73M |
| July 07, 2026 | 12.92M |
| July 06, 2026 | 13.08M |
| July 02, 2026 | 13.16M |
| July 01, 2026 | 13.26M |
| June 30, 2026 | 13.29M |
| June 29, 2026 | 10.99M |
| June 26, 2026 | 10.54M |
| June 25, 2026 | 10.62M |
| June 24, 2026 | 10.75M |
| June 23, 2026 | 10.73M |
| June 22, 2026 | 10.75M |
| June 18, 2026 | 10.62M |
| June 17, 2026 | 10.57M |
| June 16, 2026 | 10.15M |
| June 15, 2026 | 10.23M |
| June 12, 2026 | 9.883M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Harrow, Inc. | 1.708B |
| ANI Pharmaceuticals, Inc. | 1.938B |
| Corcept Therapeutics, Inc. | 13.00B |
| Veru, Inc. | 21.05M |
| Johnson & Johnson | 685.82B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.263M |
| Revenue (Quarterly) | 0.2079M |
| Total Expenses (Quarterly) | 2.470M |
| EPS Diluted (Quarterly) | -0.903 |
| Gross Profit Margin (Quarterly) | 27.32% |
| Profit Margin (Quarterly) | -1.09K% |
| Earnings Yield | -573.1% |
| Normalized Earnings Yield | -594.88 |